PBPK modeling of the antidepressant doxepin incorporating CYP2D6 genotype for precision pharmacotherapy. [PDF]
Arch Pharm ResSeok J, Kang N, Lee JJ, Cho CK, Lee YJ.
europepmc +1 more source
Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort. [PDF]
Clin Transl SciDixon P +4 more
europepmc +1 more source
Profound Synergistic Bradycardia: Pharmacokinetic Consequences of Paxlovid-Mediated CYP3A4 and CYP2D6 Inhibition on Ranolazine, Diltiazem, and Metoprolol. [PDF]
CureusBactawar SB, Gaibor C, Abdul-Waheed M.
europepmc +1 more source
Dietary-Driven Gene Expansion. [PDF]
Clin Pharmacol TherIngelman-Sundberg M.
europepmc +1 more source
Exploratory Evaluation of Solanidine as an Endogenous Marker for CYP2D6-Mediated Drug-Drug-Gene Interactions of Venlafaxine in Koreans. [PDF]
Clin Transl SciBae S +8 more
europepmc +1 more source
Pharmacogenomic Insights: The Role of CYP2D6 Allelic Variants in Drug Metabolism Among COVID-19 Patients With Comorbidities. [PDF]
In VivoÖzen M +7 more
europepmc +1 more source
Physiologically-Based Pharmacokinetic Model-Informed Labeling for Cariprazine Drug Interactions With CYP3A Inhibitors. [PDF]
CPT Pharmacometrics Syst PharmacolRiad MMH, Marroum P, Shebley M, Xiong H.
europepmc +1 more source
An Exploratory, Retrospective Study of the CYPRI Score for Pharmacogenetic Testing Among Mental Health Patients. [PDF]
Genes (Basel)Comtesse SM +3 more
europepmc +1 more source
Population Genetics of Pharmacogenetic Variants in a Greek Psychiatric Cohort of over 3000 Individuals. [PDF]
Int J Mol SciNtoumou E +6 more
europepmc +1 more source
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic Modeling. [PDF]
CPT Pharmacometrics Syst PharmacolJaiswal S +6 more
europepmc +1 more source